PODXL and cancer: The authors show that miR-5100 decreases the aggressiveness of the pancreatic cancer tumor models through the inhibition of PODXL, which promotes anti-adhesive and migratory characteristics of various cancers, and high levels of PODXL correlates with poor prognosis in many of them.